KIMBERLEE RIVERA
*** ******* **, *********, ** **803 865-***-**** adxoz1@r.postjobfree.com
Highly motivated and vastly experienced in clinical research, from budgeting contracts through close-out. I have been an effective manager of the research department for the past 10 years creating an excellent rapport with the sponsors and CROs. Well versed in reading protocols, maintaining timelines, scheduling windows and creating a productive work environment.
Experience
University Eye Specialists - 622 Smithview Dr. Maryville, TN 37803 (2007–current)
• Lead Clinical Research Coordinator
Excellent organizational/time management skills
Superior written and verbal communication skills
Proficient in MS Word, Powerpoint, Office, Excel
Manage entire research site
Excellent knowledge of GCP, ICH, FDA regulations
IRB approval/correspondence
Experienced in multiple EDC platforms, entry and query resolution
Create/complete CRFs and SOPs
Maintain associated documentation, record keeping, collection and organization of trial data
Knowledgeable in study start-up and close-out procedures
• Certified Ophthalmic Assistant
Refraction Specular Microscopy Imaging IOP measurement (Goldmann and Tonopen)
ETDRS Visual Acuity OCT Cirrus/pachymetry Humphrey Visual Field
Visucam IOL Master Keratometry
Education
Nova Southeastern University, Fort Lauderdale, FL
Bachelor of Science- Life Science
Broward Community College, Fort Lauderdale, FL
Paramedic Certificate
Certifications
Certified Ophthalmic Assistant
Clinical Trials Operations
Design and Conduct of Clinical Trials
Clinical Trials Data Management and Quality Assurance
Clinical Trials Management and Advanced Operations
Clinical Trials Analysis, Monitoring and Presentation
Sponsored Research
1. Protocol: TMI-09-1 Transcend Medical, 2012
2. Protocol: 769 Bausch & Lomb, 2013
3. Protocol: CP 11-001 Ivantis, INC., 2013
4. Protocol: OTX-13-002 Ocular Therapeutix, Inc., 2013
5. Protocol: PPL GLAU M1 Mati Therapeutics, INC., 2014
6. Protocol: FSV5-004 ForSight VISION 5, 2014
7. Protocol: FSV5-005 ForSight VISION 5, 2015
8. Protocol: AR-13324-CS304 Aerie Pharmaceuticals, Inc. 2016
9. Protocol: TMI-09-01-E Transcend Medical Inc. 2016
10. Protocol: IPC-02-2015 Inotek. 2016
11. Protocol: AR-13324-CS205 Aerie 2017
12. Protocol: GLD122e-P001 Alcon, 2018
13. Protocol: 011709IN Santen 2018
14. Protocol: 011712IN Santen 2019
15. Protocol: 188*-***-*** Allergan 2019
16. Protocol: MIM-728 Mimetogen Pharmaceuticals, 2019
17. Protocol: PRG-NY-19-001 Perrigo Pharma Int’l, 2019
18. Protocol: 06807 Site Sciences, Inc, 2020
19. Protocol: CECF843A2201 Novartis 2020
20. Protocol: 07024 Sight Sciences, Inc. 2020
21. Protocol: PRG-NY-20-002 Perrigo 2021
22. Protocol: GLD122-P004 Alcon 2021
23. Protocol: SAF312B12201 Novartis 2021
24. Protocol: DE-126 Santen 2021
25. Protocol: CLN1-07277 Sight Sciences, inc. 2021
26. Protocol: 07355 Sight Sciences, inc. 2021
27. Protocol: DF6-CL-21-02 New World Medical, 2021
28. Protocol: VT-003 Visus Therapeutics, Inc 2022
29. Protocol: AR-15512-LTSS Aerie 2022
30. Protocol: STN1013600 Santen Inc. 2022